Chancellor Financial Group WB’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,189
Closed -$378K 149
2025
Q4
$378K Buy
15,189
+3,588
+31% +$90.5K 0.26% 77
2025
Q3
$296K Buy
11,601
+314
+3% +$7.75K 0.21% 97
2025
Q2
$274K Buy
11,287
+1,139
+11% +$26.6K 0.21% 98
2025
Q1
$257K Sell
10,148
-789
-7% -$20.6K 0.21% 96
2024
Q4
$290K Buy
+10,937
New +$297K 0.23% 87

Other funds holding PFE

Chancellor Financial Group WB's PFE Position: Q1 2026 in Review

Chancellor Financial Group WB sold out of Pfizer (PFE) in Q1 2026, closing a stake of 15,189 shares — an estimated $378K sold.

Chancellor Financial Group WB first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $378K in Q4 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Chancellor Financial Group WB reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Chancellor Financial Group WB sold 15,189 Pfizer shares in Q1 2026, an estimated $378K.
  • Chancellor Financial Group WB first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
  • Chancellor Financial Group WB's Pfizer position peaked at $378K in Q4 2025.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Chancellor Financial Group WB's 13F filing for Q1 2026, filed 14 May 2026.